Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 166 entries
Sorted by: Best Match Show Resources per page
Human Th1 dichotomy: origin, phenotype and biologic activities.

Immunology

Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S.
PMID: 25284714
Immunology. 2014 Oct 05; doi: 10.1111/imm.12399. Epub 2014 Oct 05.

The great variety of pathogens present in the environment has obliged the immune system to evolve different mechanisms for tailored and maximally protective responses. Initially, two major types of CD4+ T helper (Th) effector cells were identified, and named...

Cite
Annunziato F, Cosmi L, Liotta F, et al. Human Th1 dichotomy: origin, phenotype and biologic activities. Immunology. 2014;doi: 10.1111/imm.12399.
Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., & Romagnani, S. (2014). Human Th1 dichotomy: origin, phenotype and biologic activities. Immunology, . https://doi.org/10.1111/imm.12399
Annunziato, Francesco, et al. "Human Th1 dichotomy: origin, phenotype and biologic activities." Immunology vol. (2014). doi: https://doi.org/10.1111/imm.12399
Annunziato F, Cosmi L, Liotta F, Maggi E, Romagnani S. Human Th1 dichotomy: origin, phenotype and biologic activities. Immunology. 2014 Oct 05; doi: 10.1111/imm.12399. Epub 2014 Oct 05. PMID: 25284714; PMCID: PMC4557671.
Copy Download .nbib Format: NLM
A Novel Saccadic Strategy Revealed by Suppression Head Impulse Testing of Patients with Bilateral Vestibular Loss.

Frontiers in neurology

de Waele C, Shen Q, Magnani C, Curthoys IS.
PMID: 28868046
Front Neurol. 2017 Aug 18;8:419. doi: 10.3389/fneur.2017.00419. eCollection 2017.

OBJECTIVE: We examined the eye movement response patterns of a group of patients with bilateral vestibular loss (BVL) during suppression head impulse testing. Some showed a new saccadic strategy that may have potential for explaining how patients use saccades...

Cite
de Waele C, Shen Q, Magnani C, et al. A Novel Saccadic Strategy Revealed by Suppression Head Impulse Testing of Patients with Bilateral Vestibular Loss. Front Neurol. 2017;8:419doi: 10.3389/fneur.2017.00419.
de Waele, C., Shen, Q., Magnani, C., & Curthoys, I. S. (2017). A Novel Saccadic Strategy Revealed by Suppression Head Impulse Testing of Patients with Bilateral Vestibular Loss. Frontiers in neurology, 8419. https://doi.org/10.3389/fneur.2017.00419
de Waele, Catherine, et al. "A Novel Saccadic Strategy Revealed by Suppression Head Impulse Testing of Patients with Bilateral Vestibular Loss." Frontiers in neurology vol. 8 (2017): 419. doi: https://doi.org/10.3389/fneur.2017.00419
de Waele C, Shen Q, Magnani C, Curthoys IS. A Novel Saccadic Strategy Revealed by Suppression Head Impulse Testing of Patients with Bilateral Vestibular Loss. Front Neurol. 2017 Aug 18;8:419. doi: 10.3389/fneur.2017.00419. eCollection 2017. PMID: 28868046; PMCID: PMC5563306.
Copy Download .nbib Format: NLM
The effect of strontium chloride on human periodontal ligament stem cells.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases

Romagnoli C, Zonefrati R, Galli G, Aldinucci A, Nuti N, Martelli FS, Tonelli P, Tanini A, Brandi ML.
PMID: 29354155
Clin Cases Miner Bone Metab. 2017 Sep-Dec;14(3):283-293. doi: 10.11138/ccmbm/2017.14.3.283. Epub 2017 Dec 27.

The complete repair of periodontal structures remains an exciting challenge that prompts researchers to develop new treatments to restore the periodontium. Recent research has suggested strontium ion to be an attractive candidate to improve osteogenic activity. In this study,...

Cite
Romagnoli C, Zonefrati R, Galli G, et al. The effect of strontium chloride on human periodontal ligament stem cells. Clin Cases Miner Bone Metab. 2017;14(3):283-293doi: 10.11138/ccmbm/2017.14.3.283.
Romagnoli, C., Zonefrati, R., Galli, G., Aldinucci, A., Nuti, N., Martelli, F. S., Tonelli, P., Tanini, A., & Brandi, M. L. (2017). The effect of strontium chloride on human periodontal ligament stem cells. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 14(3), 283-293. https://doi.org/10.11138/ccmbm/2017.14.3.283
Romagnoli, Cecilia, et al. "The effect of strontium chloride on human periodontal ligament stem cells." Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases vol. 14,3 (2017): 283-293. doi: https://doi.org/10.11138/ccmbm/2017.14.3.283
Romagnoli C, Zonefrati R, Galli G, Aldinucci A, Nuti N, Martelli FS, Tonelli P, Tanini A, Brandi ML. The effect of strontium chloride on human periodontal ligament stem cells. Clin Cases Miner Bone Metab. 2017 Sep-Dec;14(3):283-293. doi: 10.11138/ccmbm/2017.14.3.283. Epub 2017 Dec 27. PMID: 29354155; PMCID: PMC5762217.
Copy Download .nbib Format: NLM
SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia.

Biology

Pinto C, Berselli A, Mangone L, Damato A, Iachetta F, Foracchia M, Zanelli F, Gervasi E, Romagnani A, Prati G, Lui S, Venturelli F, Vicentini M, Besutti G, De Palma R, Giorgi Rossi P.
PMID: 32707770
Biology (Basel). 2020 Jul 22;9(8). doi: 10.3390/biology9080181.

In the coronavirus disease (COVID-19) pandemic, cancer patients could be a high-risk group due to their immunosuppressed status; therefore, data on cancer patients must be available in order to consider the most adequate strategy of care. We carried out...

Cite
Pinto C, Berselli A, Mangone L, et al. SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia. Biology (Basel). 2020;9(8)doi: 10.3390/biology9080181.
Pinto, C., Berselli, A., Mangone, L., Damato, A., Iachetta, F., Foracchia, M., Zanelli, F., Gervasi, E., Romagnani, A., Prati, G., Lui, S., Venturelli, F., Vicentini, M., Besutti, G., De Palma, R., & Giorgi Rossi, P. (2020). SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia. Biology, 9(8), . https://doi.org/10.3390/biology9080181
Pinto, Carmine, et al. "SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia." Biology vol. 9,8 (2020). doi: https://doi.org/10.3390/biology9080181
Pinto C, Berselli A, Mangone L, Damato A, Iachetta F, Foracchia M, Zanelli F, Gervasi E, Romagnani A, Prati G, Lui S, Venturelli F, Vicentini M, Besutti G, De Palma R, Giorgi Rossi P. SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia. Biology (Basel). 2020 Jul 22;9(8). doi: 10.3390/biology9080181. PMID: 32707770; PMCID: PMC7465442.
Copy Download .nbib Format: NLM
FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial.

Frontiers in oncology

Damato A, Bergamo F, Antonuzzo L, Nasti G, Iachetta F, Romagnani A, Gervasi E, Larocca M, Pinto C.
PMID: 34970487
Front Oncol. 2021 Dec 14;11:766500. doi: 10.3389/fonc.2021.766500. eCollection 2021.

The NIVACOR trial is a phase II study assessing the efficacy and safety of nivolumab in combination with FOLFOXIRI/bevacizumab in first-line setting in patients affected by metastatic colorectal cancer (mCRC) RAS/BRAF mutated. We report safety run-in results in the...

Cite
Damato A, Bergamo F, Antonuzzo L, et al. FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial. Front Oncol. 2021;11:766500doi: 10.3389/fonc.2021.766500.
Damato, A., Bergamo, F., Antonuzzo, L., Nasti, G., Iachetta, F., Romagnani, A., Gervasi, E., Larocca, M., & Pinto, C. (2021). FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial. Frontiers in oncology, 11766500. https://doi.org/10.3389/fonc.2021.766500
Damato, Angela, et al. "FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial." Frontiers in oncology vol. 11 (2021): 766500. doi: https://doi.org/10.3389/fonc.2021.766500
Damato A, Bergamo F, Antonuzzo L, Nasti G, Iachetta F, Romagnani A, Gervasi E, Larocca M, Pinto C. FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial. Front Oncol. 2021 Dec 14;11:766500. doi: 10.3389/fonc.2021.766500. eCollection 2021. PMID: 34970487; PMCID: PMC8712943.
Copy Download .nbib Format: NLM
Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040.

Cancers

Oddone E, Bollon J, Nava CR, Consonni D, Marinaccio A, Magnani C, Gasparrini A, Barone-Adesi F.
PMID: 34283067
Cancers (Basel). 2021 Jul 03;13(13). doi: 10.3390/cancers13133338.

Statistical models used to forecast malignant pleural mesothelioma (MPM) trends often do not take into account historical asbestos consumption, possibly resulting in less accurate predictions of the future MPM death toll. We used the distributed lag non-linear model (DLNM)...

Cite
Oddone E, Bollon J, Nava CR, et al. Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040. Cancers (Basel). 2021;13(13)doi: 10.3390/cancers13133338.
Oddone, E., Bollon, J., Nava, C. R., Consonni, D., Marinaccio, A., Magnani, C., Gasparrini, A., & Barone-Adesi, F. (2021). Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040. Cancers, 13(13), . https://doi.org/10.3390/cancers13133338
Oddone, Enrico, et al. "Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040." Cancers vol. 13,13 (2021). doi: https://doi.org/10.3390/cancers13133338
Oddone E, Bollon J, Nava CR, Consonni D, Marinaccio A, Magnani C, Gasparrini A, Barone-Adesi F. Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040. Cancers (Basel). 2021 Jul 03;13(13). doi: 10.3390/cancers13133338. PMID: 34283067; PMCID: PMC8267929.
Copy Download .nbib Format: NLM
Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome.

Clinical kidney journal

Trivioli G, Gopaluni S, Urban ML, Gianfreda D, Cassia MA, Vercelloni PG, Calatroni M, Bettiol A, Esposito P, Murtas C, Alberici F, Maritati F, Manenti L, Palmisano A, Emmi G, Romagnani P, Moroni G, Gregorini G, Sinico RA, Jayne DRW, Vaglio A.
PMID: 33564436
Clin Kidney J. 2020 Sep 06;14(1):332-340. doi: 10.1093/ckj/sfaa139. eCollection 2021 Jan.

BACKGROUND: Although rapidly progressive glomerulonephritis is the main renal phenotype of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), slow renal disease progression is sometimes observed. These forms have been rarely discussed; we analysed their prevalence, clinico-pathological characteristics and outcome.METHODS: We...

Cite
Trivioli G, Gopaluni S, Urban ML, et al. Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome. Clin Kidney J. 2020;14(1):332-340doi: 10.1093/ckj/sfaa139.
Trivioli, G., Gopaluni, S., Urban, M. L., Gianfreda, D., Cassia, M. A., Vercelloni, P. G., Calatroni, M., Bettiol, A., Esposito, P., Murtas, C., Alberici, F., Maritati, F., Manenti, L., Palmisano, A., Emmi, G., Romagnani, P., Moroni, G., Gregorini, G., Sinico, R. A., Jayne, D. R. W., & Vaglio, A. (2021). Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome. Clinical kidney journal, 14(1), 332-340. https://doi.org/10.1093/ckj/sfaa139
Trivioli, Giorgio, et al. "Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome." Clinical kidney journal vol. 14,1 (2021): 332-340. doi: https://doi.org/10.1093/ckj/sfaa139
Trivioli G, Gopaluni S, Urban ML, Gianfreda D, Cassia MA, Vercelloni PG, Calatroni M, Bettiol A, Esposito P, Murtas C, Alberici F, Maritati F, Manenti L, Palmisano A, Emmi G, Romagnani P, Moroni G, Gregorini G, Sinico RA, Jayne DRW, Vaglio A. Slowly progressive anti-neutrophil cytoplasmic antibody-associated renal vasculitis: clinico-pathological characterization and outcome. Clin Kidney J. 2020 Sep 06;14(1):332-340. doi: 10.1093/ckj/sfaa139. eCollection 2021 Jan. PMID: 33564436; PMCID: PMC7857823.
Copy Download .nbib Format: NLM
Muscle Physiopathology in Parathyroid Hormone Disorders.

Frontiers in medicine

Romagnoli C, Brandi ML.
PMID: 34746197
Front Med (Lausanne). 2021 Oct 22;8:764346. doi: 10.3389/fmed.2021.764346. eCollection 2021.

Parathyroid hormone disorders are a group of diseases in which secretion of parathormone (PTH) is impaired. The disorders that result are characterized by signs and symptoms associated with the persistent presence of high blood calcium levels (hypercalcemia) related to...

Cite
Romagnoli C, Brandi ML. Muscle Physiopathology in Parathyroid Hormone Disorders. Front Med (Lausanne). 2021;8:764346doi: 10.3389/fmed.2021.764346.
Romagnoli, C., & Brandi, M. L. (2021). Muscle Physiopathology in Parathyroid Hormone Disorders. Frontiers in medicine, 8764346. https://doi.org/10.3389/fmed.2021.764346
Romagnoli, Cecilia, and Brandi, Maria Luisa. "Muscle Physiopathology in Parathyroid Hormone Disorders." Frontiers in medicine vol. 8 (2021): 764346. doi: https://doi.org/10.3389/fmed.2021.764346
Romagnoli C, Brandi ML. Muscle Physiopathology in Parathyroid Hormone Disorders. Front Med (Lausanne). 2021 Oct 22;8:764346. doi: 10.3389/fmed.2021.764346. eCollection 2021. PMID: 34746197; PMCID: PMC8569254.
Copy Download .nbib Format: NLM
Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet.

Journal of lipid research

Bourgeois T, Jalil A, Thomas C, Magnani C, Le Guern N, Gautier T, Pais de Barros JP, Bergas V, Choubley H, Mazzeo L, Menegaut L, Josiane Lebrun L, Van Dongen K, Xolin M, Jourdan T, Buch C, Labbé J, Saas P, Lagrost L, Masson D, Grober J.
PMID: 33518513
J Lipid Res. 2020 Dec 17;62:100013. doi: 10.1194/jlr.RA120000737. Epub 2020 Dec 17.

Recent studies have highlighted an important role for lysophosphatidylcholine acyltransferase 3 (LPCAT3) in controlling the PUFA composition of cell membranes in the liver and intestine. In these organs, LPCAT3 critically supports cell-membrane-associated processes such as lipid absorption or lipoprotein...

Cite
Bourgeois T, Jalil A, Thomas C, et al. Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet. J Lipid Res. 2020;62:100013doi: 10.1194/jlr.RA120000737.
Bourgeois, T., Jalil, A., Thomas, C., Magnani, C., Le Guern, N., Gautier, T., Pais de Barros, J. P., Bergas, V., Choubley, H., Mazzeo, L., Menegaut, L., Josiane Lebrun, L., Van Dongen, K., Xolin, M., Jourdan, T., Buch, C., Labbé, J., Saas, P., Lagrost, L., Masson, D., & Grober, J. (2020). Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet. Journal of lipid research, 62100013. https://doi.org/10.1194/jlr.RA120000737
Bourgeois, Thibaut, et al. "Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet." Journal of lipid research vol. 62 (2020): 100013. doi: https://doi.org/10.1194/jlr.RA120000737
Bourgeois T, Jalil A, Thomas C, Magnani C, Le Guern N, Gautier T, Pais de Barros JP, Bergas V, Choubley H, Mazzeo L, Menegaut L, Josiane Lebrun L, Van Dongen K, Xolin M, Jourdan T, Buch C, Labbé J, Saas P, Lagrost L, Masson D, Grober J. Deletion of lysophosphatidylcholine acyltransferase 3 in myeloid cells worsens hepatic steatosis after a high-fat diet. J Lipid Res. 2020 Dec 17;62:100013. doi: 10.1194/jlr.RA120000737. Epub 2020 Dec 17. PMID: 33518513; PMCID: PMC7859853.
Copy Download .nbib Format: NLM
Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment.

European journal of cancer (Oxford, England : 1990)

Sculco M, La Vecchia M, Aspesi A, Pinton G, Clavenna MG, Casalone E, Allione A, Grosso F, Libener R, Muzio A, Rena O, Baietto G, Parini S, Boldorini R, Giachino D, Papotti M, Scagliotti GV, Migliore E, Mirabelli D, Moro L, Magnani C, Ferrante D, Matullo G, Dianzani I.
PMID: 35032816
Eur J Cancer. 2022 Jan 12;163:44-54. doi: 10.1016/j.ejca.2021.12.023. Epub 2022 Jan 12.

INTRODUCTION: Malignant pleural mesothelioma (MPM) is a tumour associated with asbestos exposure. Approximately, 10% of patients with MPM carry a germline pathogenic variant (PV), mostly in DNA repair genes, suggesting the occurrence of inherited predispositions.AIM: This article aimed to...

Cite
Sculco M, La Vecchia M, Aspesi A, et al. Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment. Eur J Cancer. 2022;163:44-54doi: 10.1016/j.ejca.2021.12.023.
Sculco, M., La Vecchia, M., Aspesi, A., Pinton, G., Clavenna, M. G., Casalone, E., Allione, A., Grosso, F., Libener, R., Muzio, A., Rena, O., Baietto, G., Parini, S., Boldorini, R., Giachino, D., Papotti, M., Scagliotti, G. V., Migliore, E., Mirabelli, D., Moro, L., Magnani, C., Ferrante, D., Matullo, G., & Dianzani, I. (2022). Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment. European journal of cancer (Oxford, England : 1990), 16344-54. https://doi.org/10.1016/j.ejca.2021.12.023
Sculco, Marika, et al. "Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment." European journal of cancer (Oxford, England : 1990) vol. 163 (2022): 44-54. doi: https://doi.org/10.1016/j.ejca.2021.12.023
Sculco M, La Vecchia M, Aspesi A, Pinton G, Clavenna MG, Casalone E, Allione A, Grosso F, Libener R, Muzio A, Rena O, Baietto G, Parini S, Boldorini R, Giachino D, Papotti M, Scagliotti GV, Migliore E, Mirabelli D, Moro L, Magnani C, Ferrante D, Matullo G, Dianzani I. Malignant pleural mesothelioma: Germline variants in DNA repair genes may steer tailored treatment. Eur J Cancer. 2022 Jan 12;163:44-54. doi: 10.1016/j.ejca.2021.12.023. Epub 2022 Jan 12. PMID: 35032816.
Copy Download .nbib Format: NLM
Weibel-induced filamentation during an ultrafast laser-driven plasma expansion.

Physical review letters

Quinn K, Romagnani L, Ramakrishna B, Sarri G, Dieckmann ME, Wilson PA, Fuchs J, Lancia L, Pipahl A, Toncian T, Willi O, Clarke RJ, Notley M, Macchi A, Borghesi M.
PMID: 22540706
Phys Rev Lett. 2012 Mar 30;108(13):135001. doi: 10.1103/PhysRevLett.108.135001. Epub 2012 Mar 26.

The development of current instabilities behind the front of a cylindrically expanding plasma has been investigated experimentally via proton probing techniques. A multitude of tubelike filamentary structures is observed to form behind the front of a plasma created by...

Cite
Quinn K, Romagnani L, Ramakrishna B, et al. Weibel-induced filamentation during an ultrafast laser-driven plasma expansion. Phys Rev Lett. 2012;108(13):135001doi: 10.1103/PhysRevLett.108.135001.
Quinn, K., Romagnani, L., Ramakrishna, B., Sarri, G., Dieckmann, M. E., Wilson, P. A., Fuchs, J., Lancia, L., Pipahl, A., Toncian, T., Willi, O., Clarke, R. J., Notley, M., Macchi, A., & Borghesi, M. (2012). Weibel-induced filamentation during an ultrafast laser-driven plasma expansion. Physical review letters, 108(13), 135001. https://doi.org/10.1103/PhysRevLett.108.135001
Quinn, K, et al. "Weibel-induced filamentation during an ultrafast laser-driven plasma expansion." Physical review letters vol. 108,13 (2012): 135001. doi: https://doi.org/10.1103/PhysRevLett.108.135001
Quinn K, Romagnani L, Ramakrishna B, Sarri G, Dieckmann ME, Wilson PA, Fuchs J, Lancia L, Pipahl A, Toncian T, Willi O, Clarke RJ, Notley M, Macchi A, Borghesi M. Weibel-induced filamentation during an ultrafast laser-driven plasma expansion. Phys Rev Lett. 2012 Mar 30;108(13):135001. doi: 10.1103/PhysRevLett.108.135001. Epub 2012 Mar 26. PMID: 22540706.
Copy Download .nbib Format: NLM
Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferation.

Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Cool DW, Romagnoli C, Izawa JI, Chin J, Gardi L, Tessier D, Mercado A, Mandel J, Ward AD, Fenster A.
PMID: 27800057
Can Urol Assoc J. 2016 Sep-Oct;10(9):342-348. doi: 10.5489/cuaj.3831.

INTRODUCTION: This study evaluates the clinical benefit of magnetic resonance-transrectal ultrasound (MR-TRUS) fusion biopsy over systematic biopsy between first-time and repeat prostate biopsy patients with prior atypical small acinar proliferation (ASAP).MATERIALS: 100 patients were enrolled in a single-centre prospective...

Cite
Cool DW, Romagnoli C, Izawa JI, et al. Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferation. Can Urol Assoc J. 2016;10(9):342-348doi: 10.5489/cuaj.3831.
Cool, D. W., Romagnoli, C., Izawa, J. I., Chin, J., Gardi, L., Tessier, D., Mercado, A., Mandel, J., Ward, A. D., & Fenster, A. (2016). Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferation. Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 10(9), 342-348. https://doi.org/10.5489/cuaj.3831
Cool, Derek W, et al. "Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferation." Canadian Urological Association journal = Journal de l'Association des urologues du Canada vol. 10,9 (2016): 342-348. doi: https://doi.org/10.5489/cuaj.3831
Cool DW, Romagnoli C, Izawa JI, Chin J, Gardi L, Tessier D, Mercado A, Mandel J, Ward AD, Fenster A. Comparison of prostate MRI-3D transrectal ultrasound fusion biopsy for first-time and repeat biopsy patients with previous atypical small acinar proliferation. Can Urol Assoc J. 2016 Sep-Oct;10(9):342-348. doi: 10.5489/cuaj.3831. PMID: 27800057; PMCID: PMC5085915.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 166 entries